Mandolin

Nearly every disease will become treatable in our lifetimes. Mandolin is laying the clinical and financial infrastructure to get groundbreaking treatments to patients faster, powered by AI agents. Mandolin partners closely with the largest healthcare institutions in the US, covering more than $10B drug spend across the country.

AI agentsFintechHealth and bio

Mandolin raised $40M in a Series A round announced June 25, 2025, according to mandolin.com. Investors in that round: Greylock.

Raise history

1. September 29, 2026
   First seen by Recent Funding
   via startups.gallery
2. June 25, 2025
   Series A · $40M
   GGreylock (lead)
   Source: mandolin.com (startups.gallery listing)

Investors

• GGreylock
• SSignalFire
• SSV Angel

Related other companies

• QQuartermaster$140M · Sep 28, 2026
• SSnorkel AI$350M · Sep 23, 2026
• EEnveda$311M · Sep 23, 2026
• HHeidi Health$100M · Sep 22, 2026
• FFirecrawl$75M · Sep 22, 2026
• CCorridor$25M · Sep 21, 2026
• JJack & Jill$40M · Sep 19, 2026
• MMithr Inc.$20M · Sep 19, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/mandolin.